c-erbB-3 protein expression in ductal carcinoma in situ of the breast

European Journal of Cancer

Volumn 33, Issue 11, 1997, Pages 1846-1850

  Bobrow, L G ^a   Millis, R R ^a   Happerfield, L C ^a   Gullick, W J ^b  

^a GUY S HOSPITAL   (United Kingdom)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

Breast carcinoma; C erbB 3; Ductal carcinoma in situ; Tyrosine kinase receptors

Indexed keywords

GROWTH FACTOR RECEPTOR; TYROSINE KINASE RECEPTOR;

ARTICLE; BREAST CARCINOMA; CARCINOMA IN SITU; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM PROTEINS; PROTO-ONCOGENE PROTEINS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; RECEPTOR, ERBB-3;

EID: 0031406620     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(97)00244-X     Document Type: Article

References (22)

1. Kraus MH, Issing W, Miki T, Popescu NC, Aaronson SA. Isolation and characterisation of c-erbB-3, a third member of the erbB/epidermal growth factor receptor family; evidence of over expression in a subset of human mammary tumours. Proc Natl Acad Sci USA 1989, 86, 9193-9197.
2. Prigent SA, Gullick WJ. Type I growth factor receptors and their ligands. Cancer Topics 1992, 8, 141-143.
3. Damjanov I, Mildner B, Knowles BB. Immunohistochemical localization of the epidermal growth factor receptor in normal tissues. Lab Invest 1986, 55, 588-592.
4. Press MF, Cordon-Cardo C, Slamon DJ. Expression of the HER-2/neu proto-oncogene in normal human adult and fetal tissues. Oncogene 1990, 5, 953-962.
5. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 1987, 235, 177-182.
6. Sainsbury JRC, Farndon JR, Needham GK, Malcolm AJ, Harris AL. Epidermal growth factor receptor status as predictor of early recurrence of and death from breast cancer. Lancet 1987, i, 1398-1402.
7. Gullick WJ, Love SB, Wright C, et al c-erbB-2 protein overexpression in breast cancer is a risk factor in patients with involved and uninvolved lymph nodes. Br J Cancer 1991, 63, 434-438.
8. Lovekin C, Ellis IO, Locker A, et al. c-erbB-2 oncoprotein expression in primary and advanced breast cancer. Br J Cancer 1991, 63, 439-443.
9. Ramachandra S, Machin L, Ashley S, Monaghan P, Gusterson BA. Immunohistochemical distribution of c-erbB-2 in in situ breast carcinoma-a detailed morphological analysis. J Pathol 1990, 161, 7-14.
10. Bartkova J, Barnes DM, Millis RR, Gullick WJ. Immunohistochemical demonstration of c-erbB-2 protein in mammary ductal carcinoma in situ. Human Pathol 1990, 21, 1164-1167.
11. Slamon DS, Brandt R, Ciardiello F, Narmano N. Epidermal growth factor-related peptides and their receptors in human malignancies. Crit Rev Oncol/Haematol 1995, 19, 183-232.
12. Lemoine NR, Barnes DM, Hollywood DP, et al. Expression of the erbB-3 gene product in breast cancer. Br J Cancer 1992, 66, 1116-1121.
13. Quinn CM, Ostrowski JL, Lane SA, Loney DP, Teasdale J, Benson EA. c-erbB-3 protein expression in human breast cancer; comparison with other tumour variables and survival. Histopathology 1994, 25, 247-252.
14. Gasparini G, Gullick WJ, Maluta S, et al. c-erb-3 And c-erbB-2 protein expression in node-negative breast carcinoma - an immunocytochemical study. EurJ Cancer 1994, 30A, 16-22.
15. Travis A, Finder SE, Robertson JFR, et aL c-erbB-3 in human breast carcinoma: expression and relation to prognosis and established prognostic indicators. BrJ Cancer 1996, 74, 229-223.
16. Alimandi M, Romano A, Curia MC, et al. Cooperative regrading of ErbB3 and ErbB2 in neoplastic transformation and human mammary carcinoma. Oncogene 1995, 10, 1813-1821.
17. Bobrow LG, Happerfield LC, Gregory WM, Springall RD, Mulis RR. The classification of ductal carcinoma in situ and its association with biological markers. Semin Diagnost Pathol 1994, 11, 199-207.
18. Holland R, Peterse JL, Millis RR, Eusebi V, Faverly D, van de Vijver MJ, Zafrani B. Ductal carcinoma in situ: a proposal for a new classification. Semin Diagnost Pathol 1994, 11, 167-180.
19. Rajkumar T, Majhi U, MaUigarjuna V, Shantha V, Gullick WJ. Prevalence of c-erbB-3 expression in squamous cell carcinomas of the cervix as determined by the monoclonal antibody RTJ2. IntJOncol 1995, 6, 105-109.
20. Kumer R, Shephard HM, Mendelsohn J. Regulation of phosphorylation of the c-erbB-2/Her2 gene product by a monoclonal antibody and serum growth factor(s) in human mammary carcinoma cells. Mol Cell Biol 1991, 11, 976-986.
21. Binder C, Marx D, Overhoff R, Binder L, Schauer A, Hiddemann W. Bcl-2 protein expression in breast cancer in relation to established prognostic factors and other clinicopathological variables. Ann Oncol 1995, 6, 1005-1010.
22. Joenssu H, Pylkkanen L, Toikkanen S. Bcl-2 protein expression and long-term survival in breast cancer. Am J Pathol 1994, 145, 1191-1198.